Eye itching in ophthalmology and its treatment.
Itching in the field of ophthalmology is detailed in its physiopathology and a few other aspects were described. The therapeutic modalities which have been practiced are explained. In addition to steroids and antihistaminics which are commonly used, INTAL and others, suppressors of chemical transmitter substance release, are described.
D003228:Conjunctiva / Q000503:physiopathology; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003872:Dermatitis / Q000150:complications; D004485:Eczema / Q000150:complications; D004487:Edema / Q000150:complications; D004644:Emotions; D005123:Eye / Q000503:physiopathology*; D006632:Histamine / Q000502:physiology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006358:Hot Temperature; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D007665:Ketotifen / Q000627:therapeutic use; D010770:Phosphotransferases / Q000502:physiology; D011537:Pruritus / Q000209:etiology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications; D012867:Skin / Q000503:physiopathology; D013256:Steroids / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D014581:Urticaria / Q000150:complications; D014664:Vasodilation; D014966:Xanthenes / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D013256:Steroids; D013566:Sympathomimetics; D014966:Xanthenes; C016874:RU 31156; D006632:Histamine; D010770:Phosphotransferases; D004205:Cromolyn Sodium; D007665:Ketotifen